fashion -WSS

fashion

author：knowledge 2025-08-19 15:02:27 - browse：31

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Wildfire pollution widens asthma inequities on Long Island

entertainment

WSS

The high personal cost of affirmative action for Black doctors

Reconstructing family trees of blood cells may help predict disease

Lawsuit alleges UnitedHealth Group unit illegally denied claims

‘Oppenheimer’ and the risks of AI in health care

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

10 reasons why health care startups fail

knowledge

fashion

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

ChatGPT in medicine: STAT answers readers' burning questions

What the airline industry can learn from medicine

Novavax promises a turnaround & Lilly roils the obesity market

What the US credit downgrade means for the economy, your finances

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Medicare proposal to cover medical devices draws a mixed reaction

Amazon expands telehealth clinic nationwide

knowledge

Humana’s losses in Medicare Advantage tank its stock

Amazon expands telehealth clinic nationwide

No plane should take off without an EpiPen onboard

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

What the US credit downgrade means for the economy, your finances

entertainment

hotspot

entertainment

focus